PODD * Stock Overview
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Insulet Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5,363.75 |
| 52 Week High | US$5,787.93 |
| 52 Week Low | US$3,867.64 |
| Beta | 0.74 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -11.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| PODD * | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how PODD * performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how PODD * performed against the MX Market.
Price Volatility
| PODD * volatility | |
|---|---|
| PODD * Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: Insufficient data to determine PODD *'s volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine PODD *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 2,600 | Jim Hollingshead | https://www.insulet.com |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia.
Insulet Corporation Fundamentals Summary
| PODD * fundamental statistics | |
|---|---|
| Market Cap | Mex$359.54b |
| Earnings (TTM) | Mex$83.01m |
| Revenue (TTM) | Mex$23.55b |
4,332x
P/E Ratio15.3x
P/S RatioIs PODD * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PODD * income statement (TTM) | |
|---|---|
| Revenue | US$1.31b |
| Cost of Revenue | US$499.70m |
| Gross Profit | US$805.60m |
| Other Expenses | US$801.00m |
| Earnings | US$4.60m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.066 |
| Gross Margin | 61.72% |
| Net Profit Margin | 0.35% |
| Debt/Equity Ratio | 294.2% |
How did PODD * perform over the long term?
See historical performance and comparison